Gilead Sciences Inc
(NASDAQ:GILD)
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
top performing GILD trades
![Zoe Lofgren headshot](https://clerk.house.gov/content/assets/img/members/L000397.jpg)
Zoe Lofgren
House (D-CA)
17.30%
![Greg Stanton headshot](https://clerk.house.gov/content/assets/img/members/S001211.jpg)
Greg Stanton
House (D-AZ)
2.70%
![Tommy Tuberville headshot](https://bioguide.congress.gov/bioguide/photo/T/T000278.jpg)
Tommy Tuberville
Senate (R-AL)
-2.90%
![Daniel Goldman headshot](https://clerk.house.gov/content/assets/img/members/G000599.jpg)
Daniel Goldman
House (D-NY)
-4.30%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Gilead Sciences trades made by congress members.
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock option | Purchase | Jun 14, 2024 | May 10, 2024 | Senate |
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock option | Purchase | Jun 14, 2024 | May 10, 2024 | Senate |
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock option | Purchase | Jun 14, 2024 | May 10, 2024 | Senate |
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock | Sale | Jun 14, 2024 | May 08, 2024 | Senate |
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock | Purchase | May 15, 2024 | Apr 05, 2024 | Senate |
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock option | Sale | May 15, 2024 | Apr 03, 2024 | Senate |
![]() Greg StantonHouse (D-AZ) | $1K - $15K | stock | Sale | Nov 09, 2023 | Oct 24, 2023 | House |
![]() Greg StantonHouse (D-AZ) | $1K - $15K | stock | Purchase | Nov 09, 2023 | Sep 26, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale | Aug 13, 2023 | Jul 12, 2023 | House |
![]() Zoe LofgrenHouse (D-CA) | $1K - $15K | stock | Sale | Jun 06, 2023 | May 25, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Purchase | Apr 17, 2023 | Mar 06, 2023 | House |
![]() Zoe LofgrenHouse (D-CA) | $1K - $15K | stock | Purchase | Oct 11, 2022 | Sep 09, 2022 | House |
![]() Tommy TubervilleSenate (R-AL) | $1K - $15K | stock | Sale | Feb 14, 2022 | Jan 13, 2022 | Senate |
![]() Jerry MoranSenate (R-KS) | $1K - $15K | stock | Sale | Jan 21, 2022 | Dec 21, 2021 | Senate |
![]() Jerry MoranSenate (R-KS) | $1K - $15K | stock | Sale | Jan 21, 2022 | Dec 21, 2021 | Senate |
![]() Carol MillerHouse (R-WV) | $15K - $50K | stock | Sale (Partial) | Sep 02, 2022 | Nov 10, 2021 | House |